We propose that early caffeine exposure produces physiological and cognitive alterations in a Tau pathological context, supporting our hypothesis that caffeine consumption during pregnancy may constitute a risk-factor for an earlier development of AD-related phenotypes. The gene discussed is MAPT; the disease is Alzheimer disease.